Outset Medical Inc Revenue Growth Rates (OM), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Outset Medical Inc   (NASDAQ: OM)
 

OM's Revenue Growth by Quarter and Year

Outset Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/OM/growth
https://api.csimarket.com/api/v1/companies/OM/fundamentals
https://api.csimarket.com/api/v1/companies/OM/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
OM Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 33.60
2nd Quarter June 31.64
1st Quarter March 27.10
FY 92.34

OMs Annual Revenue
Outset Medical Inc 's Revenue in the fiscal year 2025 $ 118.75 millions
Outset Medical Inc 's Revenue in the fiscal year 2024 $ 113.56 millions
Outset Medical Inc 's Revenue in the fiscal year 2023 $ 130.00 millions
Outset Medical Inc 's Revenue in the fiscal year 2022 $ 115.38 millions
Outset Medical Inc 's Revenue in the fiscal year 2021 $ 102.60 millions




OM Revenue third quarter 2026 Y/Y Growth Comment
Outset Medical Inc reported Revenue increase of 17.51% year on year in the third quarter 2026, to $ 33.60 millions, this is lower than Outset Medical Inc 's recent average Revenue rise of 62.62%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 126 other companies have achieved higher Revenue growth. While Outset Medical Inc ' s Revenue growth of 17.51% ranks overall at the positon no. 2582 in the third quarter 2026.


OM Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 17.51 %
2nd Quarter June 2.49 %
1st Quarter March -6.78 %
FY   -

Financial Statements
Outset Medical Inc 's third quarter 2026 Revenue $ 33.60 millions OM's Income Statement
Outset Medical Inc 's third quarter 2025 Revenue $ 28.59 millions Quarterly OM's Income Statement


OM Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 6.18 %
2nd Quarter June 16.75 %
1st Quarter March -10.35 %
FY (Year on Year)   -


Back to OM Growth rate Comparisons >> Back to OM Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #127
Healthcare Sector #366
Overall #2582

Revenue Y/Y Growth Statistics
High Average Low
423.04 % 62.62 % -24.99 %
(Mar 31 2021)   (Sep 30 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #127
Healthcare Sector #366
Overall #2582
Revenue Y/Y Growth Statistics
High Average Low
423.04 % 62.62 % -24.99 %
(Mar 31 2021)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Outset Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
169.39 % 12.4 % -17.98 %
(Dec 31 2019)  


OM's III. Quarter Q/Q Revenue Comment
Outset Medical Inc achieved in the III. Quarter 2026 below company average Revenue increase of 6.18% quarter on quarter, to $ 33.60 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -7.39% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 28 other companies have achieved higher Revenue quarter on quarter growth. While Outset Medical Inc 's Revenue growth quarter on quarter, overall rank is 591.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #109
Overall #591
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #29
Healthcare Sector #109
Overall #591
Revenue Q/Q Growth Statistics
High Average Low
169.39 % 12.4 % -17.98 %
(Dec 31 2019)  


OM's III. Quarter Q/Q Revenue Comment
Outset Medical Inc achieved in the III. Quarter 2026 below company average Revenue increase of 6.18% quarter on quarter, to $ 33.60 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -7.39% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 28 other companies have achieved higher Revenue quarter on quarter growth. While Outset Medical Inc 's Revenue growth quarter on quarter, overall rank is 591.


Outset Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 117.55
Y / Y Revenue Growth (TTM) -1.63 %
Year on Year Revenue Growth Overall Ranking # 2184
Seqeuential Revenue Change (TTM) 0.66 %
Seq. Revenue Growth (TTM) Overall Ranking # 2244


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Outset Medical Inc reported a decrease in Revenue by -1.63% year on year, to $118 millions, compare to the 1.19% growth at Mar 31 2026.

In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2184, from total ranking in previous quarter at 2449.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 121
Healthcare Sector # 323
Overall # 2184

Revenue TTM Y/Y Growth Statistics
High Average Low
232.01 %
 45.5 %
-14.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 121
Sector # 326
S&P 500 # 2244
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Outset Medical Inc reported a decrease in Revenue by -1.63% year on year, to $118 millions, compare to the 1.19% growth at Mar 31 2026.

In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2184, from total ranking in previous quarter at 2449.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 121
Healthcare Sector # 323
Overall # 2184

Revenue TTM Y/Y Growth Statistics
High Average Low
232.01 %
45.5 %
-14.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 121
Sector # 326
S&P 500 # 2244




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OM's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Cadre Holdings inc 30.36%$ 30.362 millions
Krystal Biotech Inc 30.21%$ 30.206 millions
Sight Sciences Inc 29.83%$ 29.828 millions
Ge Healthcare Technologies Inc 29.41%$ 29.413 millions
Moderna Inc 29.23%$ 29.232 millions
Sonoma Pharmaceuticals Inc 28.02%$ 28.016 millions
Ani Pharmaceuticals Inc27.64%$ 27.638 millions
Geron Corporation27.45%$ 27.448 millions
Vericel Corporation26.47%$ 26.470 millions
Axogen inc 26.22%$ 26.218 millions
Cardio Diagnostics Holdings Inc 25.74%$ 25.744 millions
Edap Tms Sa25.55%$ 25.549 millions
Lifestance Health Group Inc 25.30%$ 25.303 millions
Rockwell Medical inc 25.21%$ 25.210 millions
Intelligent Bio Solutions Inc 25.19%$ 25.188 millions
The Oncology Institute Inc 24.31%$ 24.313 millions
Vanda Pharmaceuticals Inc 24.10%$ 24.098 millions
Mannkind Corporation24.04%$ 24.035 millions
Castle Biosciences Inc 23.90%$ 23.901 millions
Coherus Oncology inc 23.36%$ 23.360 millions
Prestige Consumer Healthcare Inc 22.93%$ 22.929 millions
Acadia Pharmaceuticals Inc 22.85%$ 22.847 millions
Protalix Biotherapeutics inc 22.82%$ 22.822 millions
Atrium Therapeutics Inc 22.81%$ 22.814 millions
Capsovision Inc 22.44%$ 22.443 millions
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions


About Outset Medical Inc Revenue Growth Rates (OM), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Outset Medical Inc (CIK 1484612).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-447683
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Outset Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.